LEI 5493006R4KC2OI5D3470

H. LUNDBECK A/S

Group parent: LUNDBECKFONDEN

Awards tracked

21

Value

€1.3M

Countries

DK

Download sample CSV

Contract awards & public grants

From biophysical chemistry to cell biology: Deciphering the role of lipids in the toxicity and spreading of protein aggregation → H. LUNDBECK AS

European Commission · DK · Grant · 2025-07-03

—

Reducing Non-Human Primates in Non-Clinical Safety Assessment: The European Initiative on Minipig and Micropig Models → H. LUNDBECK AS

European Commission · DK · Grant · 2024-11-12

—

Beyond neuroInflammation: new Concepts to Elucidate the immune system’s vital role in Parkinson’s disease → H. LUNDBECK AS

European Commission · DK · Grant · 2024-06-25

€301,788

EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells → H. LUNDBECK AS

European Commission · DK · Grant · 2019-02-28

—

PD-MitoQUANT – A quantitative approach towards the characterisation of mitochondrial dysfunction in Parkinson's disease → H. LUNDBECK AS

European Commission · DK · Grant · 2019-02-19

—

Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain → H. LUNDBECK AS

European Commission · DK · Grant · 2018-12-14

—

European Health Data and Evidence Network → H. LUNDBECK AS

European Commission · DK · Grant · 2018-11-22

—

PET Imaging of Alpha-Synuclein Fibril Formation → H. LUNDBECK AS

European Commission · DK · Grant · 2018-08-30

—

Synaptic Dysfunction in Neuropsychiatric Disorders → H. LUNDBECK AS

European Commission · DK · Grant · 2018-08-20

€297,522

Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medici → H. LUNDBECK AS

European Commission · DK · Grant · 2018-06-04

—

Inhibiting Misfolded protein PRopagation in Neurodegenerative Diseases - Sofia ref.: 116060 → H. LUNDBECK AS

European Commission · DK · Grant · 2017-04-07

—

Real world Outcomes across the AD spectrum for better care: Multimodal data Access Platform - Sofia ref.: 116020 → H. LUNDBECK AS

European Commission · DK · Grant · 2016-12-21

—

Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976 → H. LUNDBECK AS

European Commission · DK · Grant · 2016-12-16

—

Clinical study in Parkinson's disease with two unique goals: 1) Proof-of-concept of CDNF protein for disease modification; 2) Validation of clinically → H. LUNDBECK AS

European Commission · DK · Grant · 2016-12-09

€48,750

Synaptic dysfunction in Neurodegenerative Diseases → H. LUNDBECK AS

European Commission · DK · Grant · 2016-08-31

—

Training, Research and Raising of Public Awareness in Cell Biology and Pathology of Neuroglia → H. LUNDBECK AS

European Commission · DK · Grant · 2016-08-12

€290,082

Remote Assessment of Disease and Relapse in Central Nervous System Disorders → H. LUNDBECK AS

European Commission · DK · Grant · 2016-03-31

—

Pharmaceutical Education And Research with Regulatory Links: Innovative drug development strategies and regulatory tools tailored to facilitate earlie → H. LUNDBECK AS

European Commission · DK · Grant · 2016-02-12

—

Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders → H. LUNDBECK AS

European Commission · DK · Grant · 2015-12-09

€75,000

Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: → H. LUNDBECK AS

European Commission · DK · Grant · 2015-09-02

—

Training the Next Generation of European Visual Neuroscientists for the benefit of innovation in health care and high-tech industry → H. LUNDBECK AS

European Commission · DK · Grant · 2014-12-16

€290,082

Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.